- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Israeli HMO adopts ACR imaging criteria
Maccabi Health Care Services, the second largest HMO in Israel, saw utilization of CT and MR decrease after it implemented American College of Radiology appropriateness criteria in 2002.
Maccabi Health Care Services, the second largest HMO in Israel, saw utilization of CT and MR decrease after it implemented American College of Radiology appropriateness criteria in 2002.
CT use dropped 33% and MR use fell 8.7% in the 23 months after preauthorization requirements were instituted for the two modalities, Dr. Arve Blacher said at the 2004 RSNA meeting. Costs associated with the two procedures represented 1.4% of the provider's healthcare budget.
Referring physicians must phone in MR and CT requests to a central site for authorization. The call center staff responds with either an immediate authorization or a deferral followed by a written explanation.
A phone discussion with a radiologist to explain the decision is available on demand. In disputed cases, the referring physician may still order CT, but MR imaging may not be performed until after the disposition of an appeal.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
